• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Vision treatment company AcuFocus raises $65 million | Funding Roundup

Vision treatment company AcuFocus raises $65 million | Funding Roundup

November 29, 2011 By MassDevice staff

AcuFocus logo

AcuFocus Inc. raised $65 million in investments and equity financing in support of its Kamra corneal inlay treatment for near vision loss, or presbyopia.

The Kamra device is already on the market in areas in Europe, Asia-Pacific, the Middle East and South America, according to a press release.

It has CE Mark approval in the European Union and is under an investigational device exemption in the U.S.

The inlay is designed to create a "small aperture effect," allowing the eye to see near and intermediate objects more clearly without damaging distance vision.

"Presbyopia is not a disease and cannot be prevented; it is simply the normal aging process of the eye. Previously, there has been no real solution for presbyopia, but I believe that the KAMRA inlay now fills this gap," Minnesota Eye Consultants’ Dr. Richard Lindstrom said in prepared remarks. "With 80 percent of refractive procedures occurring outside of the US, the KAMRA inlay is clearly a global business."

Cowen Healthcare Royalty Partners led the round with $30 million. Existing investors Medtronic, Bausch & Lomb, Accuitive Medical Ventures, Versant Ventures, Carlyle Group and SV Life Sciences also participated.

Funding

Here’s a roundup of other dealflow and investment news:

  • Tegal invests $300,000 in therapeutic ultrasound maker NanoVibronix
    NanoVibronix Inc., a private company developing medical products for therapeutic ultrasound wound care, received a $300,000
    from California-based Tegal Corp.
    Read more
  • Bone-building injection maker Radius Health aims for $91 million
    Radius Health Inc. closed the second of a three-tranche funding round with a total of $57.3 million raised of a hoped-for $91 million in financing.
    Read more
  • RevolutionEHR aims for $600,000 for optometric electronic health records
    Madison, Wisc.-based Revolution EHR is raising $600,000 for its electronic health record system for optometrists.

    Read more
  • Consult A Doctor wins $10K prize at Americas Venture Capital Conference
    Out of 100 candidates, Consult A Doctor won the exclusive $10,000 prize as the "Top Global innovative Venture" at the Americas Venture Capital Conference.
    Read more

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic Tagged With: AcuFocus Inc., Consult A Doctor, nanovibronix, Radius Health, RevolutionEHR

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy